Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 16:05 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
October 29, 2025 07:00 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major...
October 28, 2025 07:00 ET | Source: Lifecore Biomedical, Inc.; PolyPeptide Laboratories, Inc.

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization...
October 20, 2025 10:15 ET | Source: Research and Markets

Pen Needles Global Research Report 2025: A $4.2 Billion Market by 2030, Driven by Injection Safety, Emerging Markets, Home Healthcare and Self-Administration Trends

Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Pen Needles: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the global pen needles...
October 13, 2025 07:00 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

CHASKA, Minn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
October 08, 2025 08:28 ET | Source: Research and Markets

Injectable Drug Delivery Growth Trends and Forecast Report 2025: Market to Reach $1.38 Trillion by 2032, Driven by Biologic Innovation and Rising Chronic Disease Burden

Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Injectable Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade,...
September 12, 2025 07:22 ET | Source: Research and Markets

US Generic Injectables Market Report 2025-2033 | Key Players Expand Portfolios, Invest in R&D, and Pursue Strategic Partnerships to Strengthen Market Position Across Therapeutic Areas

Dublin, Sept. 12, 2025 (GLOBE NEWSWIRE) -- The "US Generic Injectables Market Report by Therapeutic Area 2025-2033" report has been added to ResearchAndMarkets.com's offering.The US generic...
September 05, 2025 05:50 ET | Source: Research and Markets

Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions

Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The "Lyophilized Injectable Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
September 04, 2025 16:05 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
September 02, 2025 16:05 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate in Upcoming Investor Conferences

CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...